1'758 companies found
RDP Pharma AG
Romanshorn · Since 2019
RDP Pharma AG is a privately held biotech company focused on drug discovery and development of therapeutic and delivery technologies, notably the PromptDegrader™ platform for targeted degradation of intrinsically disordered region (IDR) proteins. Its pipeline includes an orally available HPV E7 degrader and additional projects such as CROMOC (drug delivery module) and CP201 (an oral alkyletherlipid candidate for cancer treatment).
RDP PROMPT AG
Romanshorn · Since 2022
RDP PROMPT AG is a privately held biotech company developing therapeutics that identify and degrade intrinsically disordered region (IDR) proteins using the PromptDegrader™ protein modulation platform. Its projects include an E7 degrader targeting the HPV E7 oncoprotein, research on MYC, and other programs such as CROMOC and CP201.
Redbiotec AG
Schlieren · Since 2006
The core activity of Redbiotec AG is the development and production of key proteins and genetic materials for the biopharmaceutical and food industries. The company focuses on the research and development of therapeutic bacteria for the treatment of cancer and genetic diseases.
Refarmed Chemicals SA
Lugano · Since 1995
The core activity of Refarmed Chemicals Ltd. is the distribution of pharmaceutical active ingredients (Active Pharmaceutical Ingredients, API) and finished dosage forms (Finished Dosage Form, FDF) for the generic pharmaceutical industry.
Regeneron Switzerland GmbH
Basel · Since 2023
Regeneron Switzerland GmbH is a biopharmaceutical company that researches, develops, and commercializes medicines, including biologics and genetic medicines. It conducts clinical trials and maintains research and manufacturing activities to support its drug development pipeline.
Relief Therapeutics International SA
Geneva · Since 2018
Renaldee AG
Augst Bl · Since 2021
The core activity of Renaldee is the development and marketing of a natural, active vitamin D product for patients with chronic diseases, particularly those with chronic kidney disease (CKD).
Repertoire Immune Medicines (Switzerland) AG
Schlieren · Since 2018
The core activity of Repertoire Immune Medicines is the development of innovative immunotherapies for various therapeutic areas, particularly for cancer, autoimmune diseases, and infectious diseases. The company utilizes its proprietary DECODE platform to decipher the unique immune codes of the human body and develop medicines that can program the immune system to selectively eliminate tumors or restore balance to the immune system in autoimmune diseases.
ReproNovo SA
Lausanne · Since 2021
The core activity of ReproNovo is the development of innovative solutions for reproductive medicine and women's health, particularly the treatment of infertility and adenomyosis. The company focuses on developing therapeutic approaches to improve the success rates of assisted reproductive technologies and to develop new treatment options for men with hypogonadism and women with adenomyosis.
Respira AG
Hochdorf · Since 2017
Respira AG develops, manufactures and markets medical devices, food supplements and cosmetics internationally. Its product range includes nasal sprays, wound‑healing products and formulations for digestive comfort, immunity and sleep; products are dermatologically tested, formulated with hypoallergenic ingredients and produced under certifications such as GMP+ and Cosmébio. The company is part of the Pharmalys group and has expertise in infant health.
Rheinbrands GmbH
Basel · Since 2011
The core activity of RheinBrands GmbH is the development and distribution of innovative consumer healthcare products, particularly in the area of intimate care and wellness products, condoms, medical lubricants and other products for a healthy, clean and hygienic intimate area.
Rhenochem AG
Basel · Since 1990
Rhenochem AG is a pharmaceutical company offering distribution and sourcing of active pharmaceutical ingredients and finished formulations, together with contract manufacturing and technology transfer. Its services include regulatory support, pharmaceutical logistics, financing assistance and market intelligence.
Rhenopharma AG
Basel · Since 2008
The company's core activity is the development, production, packaging and distribution of pharmaceutical products and services, particularly in the field of healthcare. The company offers integrated, customized services and solutions for the pharmaceutical industry, including "Supply Chain as a Service", to increase efficiency, profitability and patient care on a global scale.
Rhizen Pharmaceuticals AG
Basel · Since 2008
The core activity of Rhizen Pharmaceuticals AG is the development and marketing of pharmaceuticals, particularly in the field of oncology (cancer treatment) and onco-supportive care. The company focuses on the discovery, development and commercialization of innovative pharmaceuticals that address multiple cancer indications. It has a deep pipeline of assets covering various oncology indications and has expertise in discovery, preclinical development, clinical development and regulatory affairs.
RIDGELINE Discovery GmbH
Basel · Since 2020
RIDGELINE Discovery GmbH creates and operates Versant‑financed biotechnology companies and develops the underlying science and technologies for new ventures. The organization conducts early‑stage drug discovery, develops platforms and therapeutic candidates, and partners with entrepreneurs, industry and academic groups.
Rivopharm SA
Manno · Since 1961
The core activity of Rivopharm is the development, manufacture and marketing of pharmaceutical products, including generic and branded medicines, dietary supplements and other health products. The company also provides services such as product formulation, packaging and regulatory affairs, and operates in more than 60 countries worldwide.
Roche Chemische Unternehmungen AG
Basel · Since 1958
Roche Diagnostics International AG
Rotkreuz · Since 1998
Roche Diagnostics International AG develops and supplies diagnostic systems and tests for hospitals, laboratories and medical practices. The organization integrates research and development, production, marketing and service functions to create instruments, fully automated in‑vitro diagnostic systems and digital solutions.
Roche Glycart AG
Schlieren · Since 2000
Roche International AG
Basel · Since 2024
Outbound Leads by COHAGALeadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Discover LeadhubHow the search works, what each filter means, and how the results come together.
Source: Federal Statistical Office, UID register